Almirall, S.A. (ALMRY) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Almirall Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.385 -- 00:00:05.490 Thank you for joining us for today's quarterly earnings update and review of Almiral's 00:00:05.490 -- 00:00:08.994 first quarter financial results of 2025. 00:00:08.994 -- 00:00:13.418 As always, we are sharing the slides we are using today in the investor section of our 00:00:13.418 -- 00:00:15.961 website at almiral.com. 00:00:15.961 -- 00:00:18.942 Please move to slide number 00:00:19.144 -- 00:00:24.650 two. Let me remind you that the information presented in this call contains forward-looking 00:00:24.650 -- 00:00:28.162 statements, which involve known and unknown risks. 00:00:28.162 -- 00:00:33.168 uncertainties, and other factors that may cause actual results to materially 00:00:33.168 -- 00:00:40.116 differ from what we are sharing today. Please move to slide number three. 00:00:40.116 -- 00:00:45.342 Presenting today are Carlos Gallardo, Chairman and Chief Executive Officer, 00:00:45.342 -- 00:00:51.609 Mike McKellan, Chief Financial Officer, and Carl Sigabar, Chief Scientific Officer. 00:00:51.609 -- 00:00:57.001 Carlos will start with the business highlights covering the first quarter of 2025. 00:00:57.001 -- 00:01:02.147 followed by an update especially on biologics as the key growth drivers 00:01:02.147 -- 00:01:07.914 on our medical dermatology portfolio. Carl will provide you with an R&D status update 00:01:07.914 -- 00:01:09.996 regarding our pipeline. 00:01:09.996 -- 00:01:15.683 And Mike will then talk you through the financials before Carlos concludes the presentation. 00:01:15.683 -- 00:01:19.087 And we open for questions. 00:01:19.087 -- 00:01:22.631 I will hand over to Carlos Gallardo, our chairman and CEO. 00:01:22.631 -- 00:01:26.073 Please move to slide number five. 00:01:27.140 -- 00:01:28.903 Thank you, ...